Phase II study of dovitinib in first-line metastatic or nonresectable primary adrenocortical carcinoma (ACC): SOGUG study 2011-03.
Paula Jimenez
No relevant relationships to disclose
Marta Guix
No relevant relationships to disclose
Nuria Lainez Milagro
No relevant relationships to disclose
Luis Leon Mateos
No relevant relationships to disclose
Maria Jose Mendez Vidal
No relevant relationships to disclose
Miguel Angel Climent Duran
No relevant relationships to disclose
Jesus Garcia-Donas
Honoraria - Novartis
Research Funding - Novartis